quantisnow
FeedTopReportsPricing
⌘K
Live feed
15:22:40·100d
ANALYSTRating
BioAtla Inc. logo

Rodman & Renshaw initiated coverage on BioAtla with a new price target

BCAB· BioAtla Inc.
Health Care
Original source

Companies

  • BCAB
    BioAtla Inc.
    Health Care

Recent analyst ratings

  • Jan 13UpdateRodman & Renshaw$4.00
  • Aug 13UpdateCitizens JMP-
  • Nov 13UpdateH.C. Wainwright-
  • Sep 15UpdateJMP Securities$17.00
  • May 5UpdateCredit Suisse$5.00
  • Mar 21UpdateH.C. Wainwright$25.00

Related

  • SEC21d
    BioAtla Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC23d
    SEC Form S-8 filed by BioAtla Inc.
  • SEC23d
    BioAtla Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC23d
    SEC Form 10-K filed by BioAtla Inc.
  • PR23d
    BioAtla Announces Share Consolidation
  • PR23d
    BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
  • SEC31d
    BioAtla Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders
  • INSIDER42d
    Chief Medical Officer Sievers Eric was granted 240,000 shares, increasing direct ownership by 67% to 598,705 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022